Trinity Biotech reported $28.62M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Bayer BAYN:GR € 4316M 927M
Bio Rad Laboratories BIO:US $ 859.9M 127.07M
Cytori Therapeutics CYTX:US $ 21.28M 4.12M
Edap Tms EDAP:US $ 45.41M 0.45M
Mesa Laboratories MLAB:US $ 278.29M 2.58M
Orasure Technologies OSUR:US $ 134.96M 23.16M
Oxford Immunotec Global OXFD:US $ 160.62M 4.87M
Siemens SIE:GR € 9545M 1133M
Sientra SIEN:US $ 66.13M 16.29M
Surmodics SRDX:US $ 31.15M 31.02M
Thermo Fisher Scientific TMO:US $ 12027M 5004M
Tosoh 4042:JP Y 136660M 10452M
Trinity Biotech TRIB:US $ 28.62M 3.66M
Veracyte VCYT:US $ 164.03M 163.52M